Predictive and Impact of Pain After 6 Months of Radiotherapy, in Head and Neck Cancer

Launched by UNIVERSITY HOSPITAL, CAEN · Aug 16, 2022

Keywords

ClinConnect Summary

This clinical trial is studying how pain affects people with head and neck cancer six months after they finish radiotherapy treatment. Researchers want to understand how ongoing pain might be linked to habits like smoking and drinking alcohol, feelings of depression, tiredness, and overall quality of life. The goal is to find out what factors influence patients’ well-being and survival, so better support and education programs can be developed to help people manage their pain and maintain healthier lifestyles after treatment.

The study is open to adults with head and neck cancer who are undergoing radiotherapy for the first time, who are in stable condition, and who can speak French. If you join, you will be part of a group of about 120 patients being followed for at least six months after treatment. Participants will be monitored to see how their pain and other symptoms develop over time. This information will help doctors understand the challenges patients face and improve care for future patients.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients with a first Head and neck cancer whose therapeutic sequence involves radiotherapy
• • Patient over 18 years of age
• • Having given written consent
• • patient not previously treated with radiotherapy
• • Life expectancy \> 3 months
• • World Health Organization (WHO) score \< 3
• • Histologically proven Head and Neck cancer
• • Stable patient, with no signs of recurrence or other progressive neoplasia at the time of the examination
• • Patient treated with radiotherapy
• • Patient fluent in French
• Exclusion Criteria:
• • Non-consenting patient
• • History of malignancy, other than treated and cured basal cell or cervical cancer
• • Patient who has had a salvage surgery other than lymph node removal
• • Patient with evidence of recurrence or other progressive neoplasia at the time of examination
• • Patient who has had previous mutilating surgery (causing sequelae of swallowing and eating)
• • Uncontrolled infectious pathology
• • Patient under 18 years of age
• • Patient who is not fluent in French
• • Patient with a psychiatric pathology that could disrupt the study or prevent the interpretation of the results.